Do bisphosphonate tablets improve bone health in patients on dialysis

Phase 3

• Conditions: End Stage Kidney Disease; fracture risk; Renal and Urogenital - Kidney disease; Musculoskeletal - Osteoporosis

• Registration Number: ACTRN12620000321943
• Lead Sponsor: Westmead Hospital Research and Education Network

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-09
• Last Update Posted: 16 March 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

age 50 and over
Satellite haemodialysis

Exclusion Criteria

Planned parathyroid surgery
Planned living related kidney transplant surgery within 12 months
Active non skin malignancy
Bilateral hip replacement making DXA hip bone mineral density impossible and hip structural analysis impossible
Gastro oesophageal reflux or gastritis or peptic ulcer disease symptoms that are not controlled with regular medications
A serum parathyroid hormone (PTH) level less than 2 times the upper normal range of the intact-PTH assay
A serum alkaline phosphatase (ALP) level below the normal lower range
Inability to provide informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified